Targeting Myelogenous Leukemia Stem Cells: Role of the Circulation.
Unlike stem cells from solid tumors, the stem cells which initiate myelogenous leukemias arise in marrow, an organ with a unique circulation which allows ready access of leukemia cells, including leukemia stem cells, to the vasculature. This poses unique problems in the targeting of leukemic stem c...
Main Author: | Jane eLiesveld |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00086/full |
Similar Items
-
Wnt Signaling Pathway and Chronic Myelogenous Leukemia
by: HOU Yan, et al.
Published: (2019-02-01) -
Signaling pathways governing the behaviors of leukemia stem cells
by: Shirin Azizidoost, et al.
Published: (2024-03-01) -
Novel Treatment Strategies Utilizing Immune Reactions against Chronic Myelogenous Leukemia Stem Cells
by: Maiko Matsushita
Published: (2021-10-01) -
Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells
by: Lindsey A. Murphy, et al.
Published: (2023-12-01) -
Resveratrol, cancer and cancer stem cells: A review on past to future
by: Vasanth K. Bhaskara, et al.
Published: (2020-11-01)